Development and comparison of single FLT3-inhibitors to dual FLT3/TAF1-inhibitors as an anti-leukemic approach

• Robert S. Leigh,

  Roles Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Writing – original draft, Writing – review & editing

  Affiliation Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland

  ⨯
• Bogac L. Kaynak,

  Roles Conceptualization, Formal analysis, Funding acquisition, Writing – review & editing

  Affiliation Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland

  ⨯
• Heikki Ruskoaho,

  Roles Conceptualization, Formal analysis, Funding acquisition, Writing – review & editing

  Affiliation Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland

  ⨯
• Mika J. Välimäki

  Roles Conceptualization, Data curation, Formal analysis, Investigation, Writing – original draft, Writing – review & editing

  * E-mail: mika.valimaki@helsinki.fi

  Affiliation Drug Research Program, Division of Pharmacology and Pharmacotherapy, Faculty of Pharmacy, University of Helsinki, Helsinki, Finland

  https://orcid.org/0000-0002-9687-8197

  ⨯